2 results match your criteria: "From the Center for Musculoskeletal Research and.[Affiliation]"

Low-Dose and Short-Duration Matrix Metalloproteinase 9 Inhibition Does Not Affect Adhesion Formation during Murine Flexor Tendon Healing.

Plast Reconstr Surg

March 2016

Rochester, N.Y.; and St. Louis, Mo. From the Center for Musculoskeletal Research and Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center; the University of Rochester School of Medicine and Dentistry; and the Department of Orthopaedic Surgery, Washington University School of Medicine.

Background: After flexor tendon injury and repair, adhesion formation is a substantial concern, as it can result in loss of motion and functional disability. Matrix metalloproteinase 9 (Mmp9) is a gelatinase that contributes to degradation of extracellular matrix and is expressed during flexor tendon healing. Mmp9(-/-) mice have accelerated remodeling of adhesions during flexor tendon healing, relative to wild-type mice.

View Article and Find Full Text PDF

Metabolic reprogramming in cancer is manifested by persistent aerobic glycolysis and suppression of mitochondrial function and is known as the Warburg effect. The Warburg effect contributes to cancer progression and is considered to be a promising therapeutic target. Understanding the mechanisms used by cancer cells to suppress their mitochondria may lead to development of new approaches to reverse metabolic reprogramming.

View Article and Find Full Text PDF